VIE/ALGN (VIE/ALGN)

Vienna Stock Exchange: VIE/ALGN · EUR

€138

+1.85 (+1.4%)· Recorded snapshot

Market cap	9.8B
Revenue (ttm)	3.7B
Net income (ttm)	433.1M
EPS (ttm)	€6.17
P/E (trailing)	22.4x
P/E (forward)	13.4x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.7B
Net income (ttm): 433.1M
EPS (ttm): €6.17
P/E (trailing): 22.4x
P/E (forward): 13.4x
Market cap: 9.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E13.4

P25 14.3P50 18.7P75 25.4

Trailing P/E22.4

P25 20.4P50 26.7P75 39.7

ROE11.9

P25 4.8P50 10.6P75 20.1

ROIC19.3

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/ALGN indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-28
Employees	20,435
Employees change	-15
Employees growth	-0.07%
Enterprise value	EUR 8.9B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1997
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US0162551016
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Market cap	EUR 9.8B
Next earnings date	2027-02-03
Price	EUR 138.25
Price currency	EUR
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-28
Symbol	vie/ALGN
Website	https://www.aligntech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	48.35x
Average P/E ratio (3Y)	34.24x
Average P/E ratio (5Y)	43.3x
Earnings yield	4.46%
EV/Earnings	20.47x
EV/EBIT	11.98x
EV/EBITDA	9.7x
EV/FCF	15.55x
EV/Sales	2.38x
FCF / EV yield	6.43%
FCF yield	5.82%
Forward P/E	13.39x
Graham number	85.82947
Graham upside	-37.92%
Lynch fair value	EUR 30.58
Lynch upside	-77.88%
P/(FCF - SBC) ratio	24.09x
P/(OCF - SBC) ratio	19.71x
P/B ratio	2.58x
P/E ratio	22.42x
P/FCF ratio	17.17x
P/OCF ratio	14.83x
P/S ratio	2.67x
Price / tangible book value	2.99x
Price/EBITDA ratio	11.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.84%
EBITDA margin	23.33%
Effective tax rate	23.65%
FCF margin	15.27%
Gross margin	71.72%
Operating margin	19.84%
Pretax margin	15.49%
Profit margin	11.83%
Profit per employee	EUR 21,196
Profitable quarters	24
Profitable years	16
Revenue per employee	EUR 179,206
ROA	8.08%
ROA (5Y)	7.76%
ROCE	17.9%
ROE	11.91%
ROE (5Y)	13.3%
ROIC	19.31%
ROIC (5Y)	18.81%
SBC / revenue	4.47%
Tax / revenue	3.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	33.19%
EPS growth (Q)	143.59%
EPS growth (QoQ)	25.83%
EPS growth 10Y	11.37%
EPS growth 3Y	13.44%
EPS growth 5Y	-5.84%
EPS growth years	1
FCF growth	14.26%
FCF growth (Q)	47.59%
FCF growth (QoQ)	58.74%
FCF growth 3Y	-1.91%
FCF growth 5Y	-7.11%
Gross profit growth	8.37%
Gross profit growth (Q)	4.55%
Gross profit growth 3Y	3.96%
Gross profit growth 5Y	1.26%
Net income growth	29.99%
Net income growth (Q)	137.95%
Net income growth (QoQ)	24.7%
Net income growth 3Y	10.68%
Net income growth 5Y	-7.85%
Net income growth years	0
OCF growth	14.29%
OCF growth (Q)	-3.08%
OCF growth (QoQ)	-5.1%
OCF growth 10Y	11.79%
OCF growth 3Y	-5.32%
OCF growth 5Y	-10.16%
Operating income growth	30.63%
Operating income growth (Q)	23.7%
Operating income growth 3Y	11.45%
Operating income growth 5Y	-3.16%
Revenue growth	4.42%
Revenue growth (Q)	1.92%
Revenue growth (QoQ)	-3.92%
Revenue growth 10Y	15.12%
Revenue growth 3Y	2.99%
Revenue growth 5Y	2.06%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -90.2M
Depreciation and amortization	EUR 130.5M
EBIT	EUR 726.4M
EBITDA	EUR 854.4M
EPS	EUR 6.17
Financing cash flow	EUR -271.1M
Free cash flow	EUR 570.1M
Free cash flow minus SBC	EUR 406.5M
Gross profit	EUR 2.6B
Income taxes	EUR 134.2M
Investing cash flow	EUR -261.3M
Net cash flow	EUR 123.7M
Net income	EUR 433.1M
Operating cash flow minus SBC	EUR 496.7M
Operating income	EUR 726.4M
Revenue	EUR 3.7B
Stock-based compensation	EUR 163.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 53.41
Debt / EBITDA	0.11
Debt / equity	0.03
Debt / FCF	0.17
Goodwill	EUR 444.6M
Long-term assets	EUR 3.3B
Long-term liabilities	EUR 232.7M
Net cash (debt)	EUR 909.3M
Net cash / market cap	9.29%
Net cash growth	16.9%
Net debt / EBITDA	-1.06
Net debt / equity	-0.24
Net debt / FCF	-1.59
Piotroski F-Score	7
Property, plant and equipment	EUR 1.1B
Shareholders' equity	EUR 3.8B
Tangible book value	EUR 3.3B
Tangible book value per share	EUR 46.14
Total assets	EUR 5.7B
Total cash	EUR 1B
Total debt	EUR 98.9M
Total liabilities	EUR 2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	EUR 2.4B
Current liabilities	EUR 1.7B
Current ratio	1.42
Inventory turnover	5.19
Net working capital	EUR -292.7M
Quick ratio	1.21
Working capital	EUR 715.6M
Working capital turnover	5.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.39%
Shareholder yield	2.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 144.53
1D price change	1.36%
1M price change	6.8%
1M total return	6.8%
1W price change	4.14%
1W total return	4.14%
1Y price change	18.67%
1Y return CAGR	18.68%
1Y total return	18.67%
20-day SMA	EUR 130.61
200-day SMA	EUR 146.13
3M price change	-5.11%
3M total return	-5.11%
3Y price change	-23.68%
3Y return CAGR	-8.61%
3Y total return	-23.68%
50-day SMA	EUR 132.28
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 167.55
52-week high date	2026-04-21
52-week low	EUR 112.80
52-week low date	2025-11-18
5Y price change	-72.98%
5Y return CAGR	-23.03%
5Y total return	-72.98%
6M price change	-13%
6M total return	-13%
All-time high	EUR 622.00
All-time high date	2021-09-27
All-time low	EUR 105.45
All-time low date	2025-10-01
Average true range (ATR)	EUR 2.51
Average volume	6.9
Change from 52-week high	-17.49%
Change from 52-week low	22.56%
Change from all-time high	-77.77%
Change from all-time low	31.1%
Change from open	0.66%
Day's gap	0.7%
High price	EUR 138.70
Low price	EUR 135.40
Monthly RSI	42.73
Open price	EUR 137.35
Position in 52-week range	86.36%
Previous close	EUR 136.40
Price vs 150-day SMA	-4.35%
Price vs 20-day SMA	5.85%
Price vs 200-day SMA	-5.39%
Price vs 50-day SMA	4.51%
Relative volume	19.57
RSI	63.77
Sharpe ratio	0.5
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.35
Sortino ratio	0.98
Sortino ratio (3Y)	-0.22
Sortino ratio (5Y)	-0.37
Weekly RSI	48.57
YTD price change	2.98%
YTD total return	2.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66.8M
Shares change (QoQ)	-0.71%
Shares change (YoY)	-2.39%
Shares held by insiders	3.42%
Shares held by institutions	102.95%

Deeper analysis on VIE/ALGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ALGN report

Is a complete VIE/ALGN research report available?

No complete published report is available for vie/ALGN (VIE/ALGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ALGN (VIE/ALGN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ALGN

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/ALGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ALGN

Frequently asked questions